Q4 2024 Management View CEO Panna Sharma highlighted 2024 as a transformational year, emphasizing the company's advancements in computational and AI-driven drug discovery, particularly in precision ...
Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage biopharmaceutical company leveraging its proprietary RADR® artificial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback